S&P 500   3,986.02 (+0.87%)
DOW   32,425.84 (+0.56%)
QQQ   308.50 (+0.83%)
AAPL   158.67 (+0.81%)
MSFT   271.65 (-0.21%)
META   200.55 (+1.39%)
GOOGL   104.16 (+2.90%)
AMZN   100.15 (+2.50%)
TSLA   196.06 (+6.99%)
NVDA   261.26 (+0.87%)
NIO   9.33 (+6.63%)
BABA   83.44 (+3.01%)
AMD   95.92 (-0.92%)
T   18.47 (-0.11%)
F   11.69 (+4.56%)
MU   58.24 (+1.04%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.36 (-1.10%)
PYPL   75.89 (+3.66%)
NFLX   304.67 (-0.15%)
S&P 500   3,986.02 (+0.87%)
DOW   32,425.84 (+0.56%)
QQQ   308.50 (+0.83%)
AAPL   158.67 (+0.81%)
MSFT   271.65 (-0.21%)
META   200.55 (+1.39%)
GOOGL   104.16 (+2.90%)
AMZN   100.15 (+2.50%)
TSLA   196.06 (+6.99%)
NVDA   261.26 (+0.87%)
NIO   9.33 (+6.63%)
BABA   83.44 (+3.01%)
AMD   95.92 (-0.92%)
T   18.47 (-0.11%)
F   11.69 (+4.56%)
MU   58.24 (+1.04%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.36 (-1.10%)
PYPL   75.89 (+3.66%)
NFLX   304.67 (-0.15%)
S&P 500   3,986.02 (+0.87%)
DOW   32,425.84 (+0.56%)
QQQ   308.50 (+0.83%)
AAPL   158.67 (+0.81%)
MSFT   271.65 (-0.21%)
META   200.55 (+1.39%)
GOOGL   104.16 (+2.90%)
AMZN   100.15 (+2.50%)
TSLA   196.06 (+6.99%)
NVDA   261.26 (+0.87%)
NIO   9.33 (+6.63%)
BABA   83.44 (+3.01%)
AMD   95.92 (-0.92%)
T   18.47 (-0.11%)
F   11.69 (+4.56%)
MU   58.24 (+1.04%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.36 (-1.10%)
PYPL   75.89 (+3.66%)
NFLX   304.67 (-0.15%)
S&P 500   3,986.02 (+0.87%)
DOW   32,425.84 (+0.56%)
QQQ   308.50 (+0.83%)
AAPL   158.67 (+0.81%)
MSFT   271.65 (-0.21%)
META   200.55 (+1.39%)
GOOGL   104.16 (+2.90%)
AMZN   100.15 (+2.50%)
TSLA   196.06 (+6.99%)
NVDA   261.26 (+0.87%)
NIO   9.33 (+6.63%)
BABA   83.44 (+3.01%)
AMD   95.92 (-0.92%)
T   18.47 (-0.11%)
F   11.69 (+4.56%)
MU   58.24 (+1.04%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.33 (+2.24%)
AMC   4.40 (+3.04%)
PFE   40.36 (-1.10%)
PYPL   75.89 (+3.66%)
NFLX   304.67 (-0.15%)
NYSE:NHI

National Health Investors - NHI Price Target & Analyst Ratings

$50.94
-0.76 (-1.47%)
(As of 03/21/2023 02:14 PM ET)
Add
Compare
Today's Range
$50.85
▼
$52.31
50-Day Range
$50.97
▼
$59.60
52-Week Range
$50.22
▼
$67.16
Volume
93,627 shs
Average Volume
274,443 shs
Market Capitalization
$2.21 billion
P/E Ratio
34.65
Dividend Yield
7.07%
Price Target
$61.25

National Health Investors Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$61.25
20.24% Upside
High Prediction$64.00
Average Prediction$61.25
Low Prediction$58.00
TypeCurrent
3/21/22 to 3/21/23		1 Month Ago
2/19/22 to 2/19/23		3 Months Ago
12/21/21 to 12/21/22		1 Year Ago
3/21/21 to 3/21/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$61.25$61.25$61.25$66.40
Predicted Upside20.24% Upside4.04% Upside4.04% Upside6.97% Upside
Get National Health Investors Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter.

NHI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NHI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

National Health Investors Stock vs. The Competition

TypeNational Health InvestorsFinance CompaniesS&P 500
Consensus Rating Score
2.25
2.43
2.47
Consensus RatingHoldHoldHold
Predicted Upside18.47% Upside92.81% Upside23.16% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/9/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Neutral$47.00 ➝ $58.00+2.58%
9/26/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetHold$64.00 ➝ $61.00+2.97%
6/21/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		John Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Market Perform$62.00+2.04%
6/3/2022Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		D. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated CoverageOverweight ➝ Overweight$64.00+8.59%
7/23/2021Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetEqual Weight$74.00 ➝ $72.00+6.56%
1/13/2021Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeNeutral ➝ Underperform$56.00 ➝ $55.00-16.91%
12/14/2020KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Sector Weight
12/2/2020Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold
9/1/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingHold$63.00+0.67%
6/24/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHold$61.00 ➝ $64.00+10.80%
6/8/2020JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform
(Data available from 3/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NHI Price Target - Frequently Asked Questions

What is National Health Investors's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for National Health Investors stock is Hold based on the current 3 hold ratings and 1 buy rating for NHI. The average twelve-month price prediction for National Health Investors is $61.25 with a high price target of $64.00 and a low price target of $58.00. Learn more on NHI's analyst rating history.

Do Wall Street analysts like National Health Investors more than its competitors?

Analysts like National Health Investors less than other Finance companies. The consensus rating score for National Health Investors is 2.25 while the average consensus rating score for finance companies is 2.43. Learn more on how NHI compares to other companies.

Does National Health Investors's stock price have much upside?

According to analysts, National Health Investors's stock has a predicted upside of 4.04% based on their 12-month price targets.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NYSE:NHI) was last updated on 3/21/2023 by MarketBeat.com Staff